Bristol-Myers Squibb
BMY
$70.71
Share price
-0.81%
Change (1 day)
17.40%
Change (1 year)
Categories
Earnings for Bristol-Myers Squibb (BMY)
Earnings in 2022 (TTM): $7.66 B
According to Bristol-Myers Squibb's latest financial reports the company's current earnings (TTM) are $7.66 B. In 2021 the company made an earning of $8.09 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bristol-Myers Squibb from 2003 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $7.66 B | -5.41% |
| 2021 | $8.09 B | |
| 2018 | $5.96 B | |
| 2014 | $2.38 B | -17.64% |
| 2013 | $2.89 B | 23.55% |
| 2012 | $2.34 B | |
| 2009 | $5.60 B | |
| 2007 | $3.53 B | |
| 2004 | $4.41 B | -5.88% |
| 2003 | $4.69 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $20.51 B | 167.82% | 🇺🇸 USA |
 Novartis NVS | $24.89 B | 224.96% | 🇨🇭 Switzerland |
 Pfizer PFE | $33.77 B | 340.89% | 🇺🇸 USA |
 AbbVie ABBV | $14.07 B | 83.69% | 🇺🇸 USA |
 Eli Lilly LLY | $6.22 B | -18.67% | 🇺🇸 USA |
 Amgen AMGN | $7.49 B | -2.19% | 🇺🇸 USA |
 Sanofi SNY | $9.45 B | 23.45% | 🇫🇷 France |
 Biogen BIIB | $2.31 B | -69.80% | 🇺🇸 USA |
 Merck MRK | $19.41 B | 153.41% | 🇺🇸 USA |
 Astrazeneca AZN | -$0.55 B | -107.09% | 🇬🇧 UK |